share_log

JMP Securities Downgrades Athira Pharma to Market Perform

Benzinga ·  Sep 5 00:13

JMP Securities analyst Jason Butler downgrades Athira Pharma (NASDAQ:ATHA) from Market Outperform to Market Perform.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment